You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Eye conditions

Ciclosporin for treating dry eye disease that has not improved despite treatment with artificial tears

  • Technology appraisal guidance
  • Reference number: TA369
  • Published:  16 December 2015
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History
Download guidance (PDF)
  • Overview
  • 1 Guidance
  • 2 The technology
  • 3 The company's submission
  • 4 Consideration of the evidence
  • 5 Implementation
  • 6 Appraisal Committee members, guideline representatives and NICE project team
  • 7 Sources of evidence considered by the Committee

1 Guidance

1.1

Ciclosporin is recommended as an option, within its marketing authorisation, for treating severe keratitis in adult patients with dry eye disease that has not improved despite treatment with tear substitutes.


Next page 2 The technology Previous page Overview
Back to top